Page last updated: 2024-09-04

docetaxel anhydrous and Lung Adenocarcinoma

docetaxel anhydrous has been researched along with Lung Adenocarcinoma in 56 studies

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's44 (78.57)24.3611
2020's12 (21.43)2.80

Authors

AuthorsStudies
Fukushima, K; Hashida, N; Hirata, H; Iwahori, K; Koyama, S; Kuge, T; Kumanogoh, A; Matsumoto, K; Miyake, K; Nagatomo, I; Naito, Y; Shiroyama, T; Suga, Y; Takeda, Y; Yamamoto, M; Yamamoto, Y; Yoneda, M1
Chang, L; Chen, F; Chen, J; Fang, S; Gu, W; Li, C; Liu, W; Ma, J; Qian, Y; Yang, Z; Yuan, Y; Zhang, K1
Hashimoto, M; Hojo, M; Iikura, M; Ishida, A; Ishii, S; Izumi, S; Naka, G; Sugiyama, H; Ushio, A1
Igai, H; Kamiyoshihara, M; Matsuura, N; Numajiri, K; Ohsawa, F1
Bourlon, MT; Gabutti, A; Remolina-Bonilla, YA; Saldivar-Oviedo, B; Trejo-Rosales, RR1
Hoffman, RM; Hu, L; Liu, JB; Sun, YU; Yang, Z; Yi, Z1
Bi, J; Chen, S; Diao, C; Dong, Y; Fan, H; Fan, W; Feng, Q; Geng, D; Han, X; Huang, G; Li, F; Li, G; Li, P; Li, Q; Li, T; Li, W; Li, Y; Liu, B; Meng, M; Meng, Q; Ni, Y; Ren, H; Sheng, L; Sun, D; Sun, L; Sun, W; Sun, Y; Tian, H; Wang, C; Wang, J; Wei, Z; Xu, X; Xu, Y; Xue, G; Yang, X; Ye, X; Yu, G; Zhang, B; Zhang, K; Zhang, L; Zheng, A; Zou, Z1
Li, J; Li, W; Liang, L; Liu, Z; Wang, Y; Xu, F; Xu, H; Yang, G; Yang, L; Ying, J; Zhang, Q; Zhang, S1
Acevedo-Delgado, JA; Acosta-Espinoza, A; Alatorre-Alexander, JA; Astorga-Ramos, AM; Barriguete-Parra, L; Campos-Gomez, S; Capdeville-García, D; Cázarez-Price, JC; Ceja-García, JP; Fernández-Garibay, VM; Flores-Anaya, N; Flores-Mariñelarena, RR; García-Montes, V; Gerson-Cwilich, R; González-Espinoza, IR; Gonzalez-Villanueva, JI; Kuri-Exsome, R; Magallanes-Maciel, M; Martínez-Barrera, L; Noriega-Iriondo, MF; Perales-Rodríguez, E; Perez-Lozano, Y; Rodríguez-Cid, JR; Rodríguez-Silva, C; Suárez-García, D; Vázquez-Cortés, L; Villalobos-Prieto, A; Zuloaga-Fernandez, CJ1
Furuya, N; Hataji, O; Hida, N; Inoue, T; Ito, K; Komase, Y; Mineshita, M; Morikawa, K; Sakaguchi, T1
Ando, M; Gemma, A; Hagiwara, K; Hino, M; Kobayashi, K; Kubota, K; Miyanaga, A; Nishitsuji, M; Noro, R; Seike, M; Shimokawa, T; Usuki, J; Yomota, M1
Atz, J; Azeh, I; Buchner, H; C Christoph, D; Hoffmann, C; Hoiczyk, M; Kambartel, K; Metzenmacher, M; Panse, J; Rizzo, F; Schaufler, D; Scheffler, M; Turki, AT1
Bai, H; Han, Y; Niu, Y; Zhang, M1
Chen, J; Chen, L; Chu, X; Pan, Y; Tao, L; Wang, R; Zhang, K1
Bennouna, J; Bondarenko, I; Douillard, JY; Gottfried, M; Heigener, DF; Kaiser, R; Krzakowski, M; Mellemgaard, A; Novello, S; Orlov, S; Reck, M; Stöhr, J; Summers, Y; von Pawel, J1
Alcaraz, J; Gabasa, M; Hilberg, F; Ikemori, R; Reguart, N1
Onari, Y; Otani, T; Yamane, M1
Gao, G; Ren, S; Wu, F; Zhang, S; Zhao, J; Zhou, C1
Fukasawa, Y; Haruyama, T; Honda, T; Ichikawa, Y; Ishihara, M; Natsume, M; Ota, S; Sakamoto, T; Sasajima, Y; Seki, N; Tanzawa, S; Usui, R; Watanabe, K1
Bell, AP; Jain, N; Jarvis, SP; Kilpatrick, JI; Liu, B; Movia, D; Prina-Mello, A; Tutty, MA; Volkov, Y1
Fusumae, T; Kawakita, R; Oda, S; Takasugi, A; Takeuchi, A; Yoshida, T1
Goto, K; Horinouchi, H; Kato, T; Kenmotsu, H; Morsli, N; Nakagawa, K; Saito, I; Sarashina, A; Takeda, K; Takeda, M; Tanaka, T; Yamamoto, N1
Cao, J; Chen, L; Chu, X; Geng, J; Huang, G; Wang, R1
Geng, Y; He, Z; Li, M; Li, Q; Liu, L; Lu, B; Luo, D; Ma, Z; OuYang, W; Su, S; Wang, Y; Yang, W; Zhao, C1
Cao, S; Han, B; Teng, J; Xu, J; Zhong, H1
Gandara, DR; Knollmann, FD; Lim, S; Narayanan, A; Riess, JW; Walby, JAS1
Bai, H; Duan, JC; Hao, XZ; Hu, XS; Li, JL; Lin, L; Liu, YT; Wan, R; Wang, HY; Wang, J; Wang, X; Wang, Y; Wang, ZJ1
Carcereny, E; Corral, J; Cortes, ÁA; Domine, M; García, Y; Llorente, M; López Criado, MP; López Picazo, JM; Majem, M; Rodríguez-Abreu, D1
Cao, F; Chen, D; Chen, L; Feng, J; Wang, R; Yan, F; Yu, C; Yu, Z; Zhang, X; Zhu, H1
Asai, Y; Gon, Y; Nakagawa, Y; Shimizu, T; Takahashi, N; Tsujino, I1
Hongo, H; Kosaka, T; Oya, M1
de Castro, J; Felip, E; García-Campelo, R; Garrido, P; Isla, D; Lianes, P; Paz-Ares, L; Trigo, JM1
Chen, LB; Chen, YT; Cui, SY; De, W; Feng, B; Huang, GC; Huang, JY; Song, HZ; Wang, R1
Chen, LB; Pan, BZ; Song, HZ; Wang, R; Zhang, YW; Zheng, Y1
Barrueco, J; Bondarenko, I; Douillard, JY; Gann, CN; Gaschler-Markefski, B; Gottfried, M; Kaiser, R; Krzakowski, M; Liao, M; Mellemgaard, A; Novello, S; Orlov, S; Reck, M; von Pawel, J1
Leighl, NB; Zer, A1
Chen, D; Chen, L; Feng, B; Huang, J; Pan, B; Song, H; Wang, R1
Chen, DQ; Chen, J; Chen, LB; De, W; Feng, B; Huang, JY; Pan, BZ; Wang, R; Zhang, K1
Chen, D; Chen, J; Chen, L; De, W; Huang, J; Pan, B; Wang, R; Zhang, K1
Dhillon, S1
Bartolotti, M; Brandes, AA; Cavallo, G; Dalpiaz, G; De Biase, D; Denicolò, F; Di Battista, M; Genestreti, G; Lazzari-Agli, LA; Trisolini, R; Valli, M1
Catino, A; De Ceglie, A; Galetta, D; Logroscino, A; Misino, A; Natalicchio, MI; Simone, G1
Cui, YQ; Geng, Q; Li, J; Lin, HC; Liu, L; Yan, MX; Yao, M; Yu, T; Zhang, FL; Zhu, MX1
Chen, L; Chen, Y; Feng, B; Huang, G; Pan, B; Song, H; Wang, R1
Aggarwal, C; Bauml, J; Brady, AK; Cohen, RB; Evans, TL; Judy, B; Langer, C; McNeill, JD; Vachani, A1
Bosenberg, MW; Held, MA; Iyidogan, P; Langdon, CG; Levy, F; Mamillapalli, R; Platt, JT; Stern, DF; Theodosakis, N; Vuagniaux, G; Wang, S; Wiedemann, N1
Chen, L; Chen, Y; Feng, B; Gao, Y; Song, H; Wang, R1
Wang, K; Zhang, K; Zhou, F; Zhu, L; Zhu, X1
Chen, J; Chen, LB; Chu, X; Pan, Y; Tao, L; Wang, R; Xu, Y; Zhang, K1
Baak, JP; Guo, H; Liu, JX; Madebo, T; Xu, L1
Wang, L; Xiao, F; Zhang, W; Zheng, J1
Chen, Y; Hotta, K; Ichihara, E; Kiura, K; Ochi, N; Tabata, M; Takigawa, N; Tanimoto, M; Tanimoto, Y; Zhang, D1
Chen, LB; Feng, B; Song, HZ; Wang, R1
Liu, G; Wang, W; Zhang, X; Zhu, X1
Jiao, S; Sun, S; Wu, L; Wu, Z; Yan, X; Zhao, X1

Reviews

4 review(s) available for docetaxel anhydrous and Lung Adenocarcinoma

ArticleYear
Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.
    Cancer biology & therapy, 2018, 03-04, Volume: 19, Issue:3

    Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lung; Lung Neoplasms; Male; Neoplasm Staging; Pyridines; Tomography, X-Ray Computed; Treatment Outcome

2018
Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jun-20, Volume: 32, Issue:18

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; DNA-Binding Proteins; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Profiling; Genotype; Glutamates; Guanine; Humans; Keratin-7; Lung Neoplasms; Middle Aged; Palliative Care; Pemetrexed; Pleural Effusion, Malignant; Quinazolines; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Taxoids; Transcription Factors; Treatment Failure

2014
Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology.
    Targeted oncology, 2015, Volume: 10, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Docetaxel; Humans; Indoles; Lung Neoplasms; Protein Kinase Inhibitors; Quality of Life; Risk Factors; Survival Analysis; Taxoids; Time Factors; Treatment Outcome

2015
A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literature.
    Tumori, 2015, Jun-25, Volume: 101, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Antineoplastic Agents; Blood Gas Analysis; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Prednisone; Recovery of Function; Spirometry; Taxoids; Tomography, X-Ray Computed

2015

Trials

7 trial(s) available for docetaxel anhydrous and Lung Adenocarcinoma

ArticleYear
Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial.
    European radiology, 2020, Volume: 30, Issue:5

    Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Microwaves; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Pemetrexed; Progression-Free Survival; Prospective Studies; Radiofrequency Ablation; Treatment Outcome; Vinorelbine

2020
Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
    Thoracic cancer, 2020, Volume: 11, Issue:7

    Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Erlotinib Hydrochloride; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pemetrexed; Pleural Effusion, Malignant; Pleurodesis; Prognosis; Survival Rate

2020
Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study.
    Targeted oncology, 2017, Volume: 12, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Double-Blind Method; Europe; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Taxoids

2017
An open-label feasibility study of nintedanib combined with docetaxel in Japanese patients with locally advanced or metastatic lung adenocarcinoma after failure of first-line chemotherapy.
    Cancer chemotherapy and pharmacology, 2018, Volume: 82, Issue:4

    Topics: Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Feasibility Studies; Female; Humans; Indoles; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; No-Observed-Adverse-Effect Level; Treatment Outcome

2018
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
    Investigational new drugs, 2019, Volume: 37, Issue:4

    Topics: Adenocarcinoma of Lung; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; ErbB Receptors; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome

2019
A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer.
    The Journal of international medical research, 2019, Volume: 47, Issue:7

    Topics: Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Survival Rate

2019
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Asia; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Docetaxel; Double-Blind Method; Europe; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Proportional Hazards Models; Protein Kinase Inhibitors; Risk Factors; South Africa; Taxoids; Time Factors; Treatment Outcome

2014

Other Studies

45 other study(ies) available for docetaxel anhydrous and Lung Adenocarcinoma

ArticleYear
Opposite response of lung adenocarcinoma and its choroidal metastases upon ramucirumab plus docetaxel therapy after immunotherapy: a case report.
    Angiogenesis, 2022, Volume: 25, Issue:2

    Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Immunologic Factors; Immunotherapy; Lung Neoplasms; Ramucirumab; Treatment Outcome

2022
Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma.
    Cancer letters, 2022, 02-01, Volume: 526

    Topics: Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Exosomes; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; RNA, Long Noncoding; RNA, Small Interfering; Transfection

2022
A rare case of docetaxel-induced myositis in a patient with a lung adenocarcinoma.
    Thoracic cancer, 2022, Volume: 13, Issue:14

    Topics: Adenocarcinoma of Lung; Aged; Carcinoma, Non-Small-Cell Lung; Docetaxel; Fatigue; Humans; Lung Neoplasms; Male; Myositis; Pain

2022
[Multidisciplinary Treatment for Postoperative Recurrent Patients-Report of a Long-Term Survivor].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:10

    Topics: Adenocarcinoma of Lung; Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Mutation; Nivolumab; Pemetrexed; Survivors

2022
What Are Treatment Options After Progression in PDL-1-Positive Metastatic Lung Adenocarcinoma after Chemo/IO?
    Oncology (Williston Park, N.Y.), 2019, 08-23, Volume: 33, Issue:8

    Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bone Neoplasms; Brain Neoplasms; Carboplatin; Docetaxel; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Pemetrexed; Prognosis

2019
Aurora-A/NF-ĸB Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma.
    Anticancer research, 2019, Volume: 39, Issue:11

    Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Cell Proliferation; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Radiation Tolerance; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
Crizotinib vs platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer with different ROS1 fusion variants.
    Cancer medicine, 2020, Volume: 9, Issue:10

    Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Crizotinib; Deoxycytidine; Docetaxel; Female; Gemcitabine; Histocompatibility Antigens Class II; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oncogene Fusion; Paclitaxel; Pemetrexed; Platinum Compounds; Progression-Free Survival; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Retrospective Studies; Treatment Outcome

2020
Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.
    JCO global oncology, 2020, Volume: 6

    Topics: Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Humans; Indoles; Lung; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Taxoids; Treatment Outcome

2020
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer.
    Thoracic cancer, 2020, Volume: 11, Issue:6

    Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Safety; Prognosis; Ramucirumab; Retrospective Studies; Survival Rate

2020
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma.
    Future oncology (London, England), 2021, Volume: 17, Issue:30

    Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Humans; Immune Checkpoint Inhibitors; Indoles; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Treatment Failure

2021
[Whole-process Management of Treatment of Advanced ALK Positive Non-small Cell Lung Cancer: A Case Report].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2021, Aug-20, Volume: 24, Issue:8

    Topics: Adenocarcinoma of Lung; Adult; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cisplatin; Crizotinib; Disease Progression; Docetaxel; Humans; Lung Neoplasms; Male; Mutation; Oncogene Proteins, Fusion; Pemetrexed; Protein Kinase Inhibitors; Survival Analysis; Treatment Outcome

2021
Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
    Oncotarget, 2017, May-16, Volume: 8, Issue:20

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Microfilament Proteins; MicroRNAs; Phenotype; RNA Interference; RNA, Long Noncoding; Taxoids

2017
Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients.
    British journal of cancer, 2017, Oct-10, Volume: 117, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Docetaxel; Fibroblasts; Fibrosis; Humans; Indoles; Lung Neoplasms; Neoplasm Invasiveness; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Transforming Growth Factor beta1

2017
[A Case of Lung Cancer Associated with Drug-Induced Immune Thrombocytopenia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:11

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Humans; Lung Neoplasms; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Taxoids

2017
Paraneoplastic IgA Vasculitis in an Adult with Lung Adenocarcinoma.
    Internal medicine (Tokyo, Japan), 2018, May-01, Volume: 57, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Diagnosis, Differential; Docetaxel; Exanthema; Humans; Immunoglobulin A; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Purpura; Taxoids; Treatment Outcome; Vasculitis

2018
Culturing substrates influence the morphological, mechanical and biochemical features of lung adenocarcinoma cells cultured in 2D or 3D.
    Tissue & cell, 2018, Volume: 50

    Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Biophysical Phenomena; Cell Culture Techniques; Docetaxel; Enzyme-Linked Immunosorbent Assay; Humans; Lung Neoplasms; Microscopy, Confocal; Substrate Specificity; Taxoids; Tumor Cells, Cultured

2018
Successful treatment of extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
    The Journal of dermatology, 2018, Volume: 45, Issue:9

    Topics: Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Humans; Lung Neoplasms; Male; Oxonic Acid; Paget Disease, Extramammary; Pneumonectomy; Positron-Emission Tomography; Skin Neoplasms; Tegafur; Treatment Outcome

2018
miRNA‑885‑3p inhibits docetaxel chemoresistance in lung adenocarcinoma by downregulating Aurora A.
    Oncology reports, 2019, Volume: 41, Issue:2

    Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; NF-kappa B; Proto-Oncogene Proteins c-bcl-2

2019
Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching.
    Anti-cancer drugs, 2019, Volume: 30, Issue:3

    Topics: Adenocarcinoma of Lung; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Pemetrexed; Prognosis; Propensity Score; Retrospective Studies; Survival Rate; Young Adult

2019
Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma.
    Thoracic cancer, 2019, Volume: 10, Issue:2

    Topics: Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Pemetrexed; Retrospective Studies; Survival Rate; Vinorelbine

2019
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade.
    Clinical lung cancer, 2019, Volume: 20, Issue:3

    Topics: Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Deoxycytidine; Docetaxel; Drug Resistance; Drug Substitution; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Humans; Immunotherapy; Lung Neoplasms; Neoplasm Staging; Treatment Outcome

2019
Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019, Volume: 21, Issue:9

    Topics: Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Follow-Up Studies; Humans; Immunotherapy; Indoles; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Rate

2019
FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
    EBioMedicine, 2019, Volume: 44

    Topics: Adenocarcinoma of Lung; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hepatocyte Nuclear Factor 3-alpha; Humans; Kaplan-Meier Estimate; Male; Mice; Models, Biological; Prognosis; Protein Binding; SOXD Transcription Factors; Transcriptional Activation; Xenograft Model Antitumor Assays

2019
Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
    BMC cancer, 2019, Jun-11, Volume: 19, Issue:1

    Topics: Adenocarcinoma of Lung; Adult; Antineoplastic Agents; Docetaxel; Drug Resistance, Neoplasm; Early Detection of Cancer; Humans; Liquid Biopsy; Lung Neoplasms; Male; Neoplastic Cells, Circulating; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Taxoids; Treatment Outcome

2019
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020, Volume: 22, Issue:5

    Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Clinical Decision-Making; Consensus; Delphi Technique; Disease Progression; Docetaxel; Humans; Immunotherapy; Indoles; Lung Neoplasms; Mutation; Spain

2020
Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Base Sequence; bcl-X Protein; Caspase 3; Cell Line, Tumor; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Activation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Phenotype; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Signal Transduction; Taxoids; Up-Regulation

2013
Ganetespib AIDS lung cancer survival.
    Cancer discovery, 2013, Volume: 3, Issue:7

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Analysis; Taxoids; Triazoles; Xenograft Model Antitumor Assays

2013
Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
    The international journal of biochemistry & cell biology, 2013, Volume: 45, Issue:11

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Base Sequence; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Core Binding Factor Alpha 3 Subunit; DNA Methylation; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Activation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; Molecular Sequence Data; Prognosis; Proto-Oncogene Proteins c-akt; Signal Transduction; Taxoids

2013
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.
    Molecular cancer, 2014, Jul-05, Volume: 13

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Cytoprotection; Cytosol; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Gene Knockdown Techniques; HMGB1 Protein; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Membrane Proteins; Mice, Inbred NOD; Mice, SCID; Models, Biological; Multiprotein Complexes; Phosphatidylinositol 3-Kinases; Protein Transport; Signal Transduction; Taxoids; TOR Serine-Threonine Kinases

2014
Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.
    Oncotarget, 2014, Aug-15, Volume: 5, Issue:15

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; MicroRNAs; Proto-Oncogene Mas; Signal Transduction; Taxoids

2014
MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:17

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Silencing; Humans; Lung Neoplasms; Male; MicroRNAs; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Taxoids

2014
Bladder and gastric metastases from lung adenocarcinoma harboring codon 13 KRAS mutation: a case report with unusual clinical outcome.
    Tumori, 2015, Sep-09, Volume: 101, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Codon; Cystoscopy; Disease Progression; Docetaxel; Fatal Outcome; Female; Gastroscopy; Humans; Lung Neoplasms; Mutation; Neoplasms, Second Primary; Pemetrexed; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Salvage Therapy; Stomach Neoplasms; Taxoids; Urinary Bladder Neoplasms

2015
Establishment of a highly metastatic model with a newly isolated lung adenocarcinoma cell line.
    International journal of oncology, 2015, Volume: 47, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Proliferation; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasms, Experimental; Proteomics; Taxoids; Tumor Cells, Cultured

2015
MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.
    Oncotarget, 2015, Oct-20, Volume: 6, Issue:32

    Topics: 3' Untranslated Regions; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 12; Binding Sites; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice, Inbred BALB C; MicroRNAs; Middle Aged; RNA Interference; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; Taxoids; Time Factors; Transfection; Xenograft Model Antitumor Assays

2015
Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy.
    Oncotarget, 2015, Oct-06, Volume: 6, Issue:30

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; DNA Mutational Analysis; Docetaxel; ErbB Receptors; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Paclitaxel; Philadelphia; Proportional Hazards Models; Proto-Oncogene Proteins p21(ras); Retrospective Studies; Risk Factors; Taxoids; Time Factors; Treatment Outcome

2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells.
    Oncotarget, 2015, Nov-10, Volume: 6, Issue:35

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Azepines; Azocines; Benzhydryl Compounds; Camptothecin; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Irinotecan; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Paclitaxel; Signal Transduction; Taxoids; Time Factors; Topoisomerase Inhibitors; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2015
A double-negative feedback loop between E2F3b and miR- 200b regulates docetaxel chemosensitivity of human lung adenocarcinoma cells.
    Oncotarget, 2016, May-10, Volume: 7, Issue:19

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; E2F3 Transcription Factor; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Taxoids; Transfection; Xenograft Model Antitumor Assays

2016
FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
    Acta biochimica et biophysica Sinica, 2016, Volume: 48, Issue:9

    Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Gene Knockdown Techniques; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mitochondria; RNA Interference; Taxoids

2016
MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 41, Issue:2

    Topics: 3' Untranslated Regions; Adenocarcinoma; Adenocarcinoma of Lung; Antagomirs; Apoptosis; Base Sequence; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; MicroRNAs; Neoplasm Staging; RNA Interference; RNA, Small Interfering; Sequence Alignment; Taxoids

2017
Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy.
    Integrative cancer therapies, 2011, Volume: 10, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Drug Therapy, Combination; Drugs, Chinese Herbal; Erlotinib Hydrochloride; Female; Gefitinib; Gemcitabine; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Molecular Targeted Therapy; Neoplasm Staging; Organoplatinum Compounds; Outpatients; Paclitaxel; Platinum Compounds; Prognosis; Quinazolines; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

2011
[Sequence-dependent effect of docetaxel with gefitinib on the proliferation and signal protein expression of human lung adenocarcinoma cell SPC-A1].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2011, Volume: 14, Issue:5

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Docetaxel; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, IGF Type 1; Signal Transduction; Taxoids

2011
Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
    Cancer letters, 2011, Oct-28, Volume: 309, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; Folic Acid Antagonists; Gene Expression; Glutamates; Guanine; Humans; Immunoblotting; Irinotecan; Lung Neoplasms; Pemetrexed; Phosphoribosylglycinamide Formyltransferase; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Vinblastine; Vinorelbine

2011
MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.
    Cancer, 2012, Jul-01, Volume: 118, Issue:13

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; E2F3 Transcription Factor; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; MicroRNAs; Middle Aged; Prognosis; Taxoids; Xenograft Model Antitumor Assays

2012
[Sequence-dependent effect of docetaxel with gefitinib on the proliferation and apoptosis of lung adenocarcinoma cell H1975].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2012, Volume: 15, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Docetaxel; Female; Gefitinib; Humans; Lung Neoplasms; Male; Quinazolines; Taxoids

2012
[Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].
    Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2012, Volume: 15, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Antineoplastic Agents; Docetaxel; Female; Flow Cytometry; Glutamates; Guanine; Humans; Lung Neoplasms; Lymphocyte Count; Male; Middle Aged; Neoplasm Staging; Pemetrexed; T-Lymphocyte Subsets; Taxoids; Young Adult

2012
chemdatabank.com